Ledger.Open graph →
SEC Form D · Amendment · filed April 14, 2022

Aquyre Biosciences Inc

Offering
$5.0M
Sold
$3.7M
Exemption
Rule 506(b)
Industry
Other
Location
BOSTON, MA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (15)

Guilherme Cherman Perdigao De Oliveira · Syracuse, NYExec · Directorvan Biema & Company, LLC · NEW YORK, NYDirectorRonald W. Chilton · White Plains, NYDirectorScott A. Snow · White Plains, NYExec · DirectorWillard `. Mast · Grandview, TXDirectorThierry Thaure · Boston, MAExec · DirectorAnthony Potdevin · PORTLAND, ORDirectorJesse Shrader · PORTLAND, ORExec · DirectorAri Azhir · Boston, MADirectorAurelio Fernandez · Boston, MADirectorRoman `. Miller · Grandview, TXExec · DirectorAldo Maccari · Boston, MADirectorCarl Ager · SALT LAKE CITY, UTDirectorBertrand Le Conte Chrestien De Poly · Boston, MAExec · DirectorEmanuele Conti · SAN FRANCISCO, CADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗